Welcome back.

Inflation says it behaved but your grocery receipt disagrees. November’s data came in calm, cannabis found relief through better paperwork, and a real estate company decided insurance premiums sounded emotionally stabilizing. None of it screams excitement. All of it quietly moves money.

If you enjoy watching markets shift through process instead of spectacle, you are in the right place.

If groceries felt expensive last month, the latest CPI report gently suggests personal perception needs recalibration. November inflation came in at 2.7%, below economist expectations, while core inflation slowed to 2.6%. On paper, this marked the smallest increase since early 2021. The data reads like progress, even if shoppers continue treating dairy aisles with suspicion.

Context complicates the optimism. The government shutdown delayed the release and erased October data entirely, leaving November without a prior month comparison. That absence matters more than the headline suggests. Price collection occurred late in the month, when holiday discounts were already shaping receipts. Seasonal markdowns have a talent for improving inflation optics without solving underlying cost pressures.

Shelter inflation added another layer of discomfort. Despite accounting for roughly 35% of CPI, shelter prices were logged as nearly flat for two consecutive months. Several economists questioned how rent suddenly found restraint. Some noted that October changes may have been effectively neutralized, which would mechanically lower the November reading. The broader trend likely points toward cooling inflation, but policymakers appear uninterested in celebrating yet. Until cleaner data arrives, the Federal Reserve seems content to wait, while consumers quietly continue side eyeing yogurt prices.

Cannabis did not become federally legal, but it did become federally manageable. The executive order reclassifies marijuana from Schedule I to Schedule III, signaling a softer regulatory posture without rewriting criminal statutes. The change looks technical until its financial consequences appear.

Tax treatment stands out immediately. Under Schedule III, cannabis companies can deduct ordinary business expenses, reversing years of structurally inflated tax burdens. This adjustment improves profitability through compliance rather than consumption growth. Investors often favor that kind of progress.

Banking access follows naturally. Reduced compliance risk allows financial institutions to engage without excessive legal gymnastics. Capital that previously stayed sidelined now has justification to explore exposure. Insurance and investment structures become simpler, which lowers operating friction across the sector.

Medical research benefits as well. Easier approvals encourage studies that previously stalled under Schedule I restrictions. The order also emphasizes expanded CBD research, with the added possibility of Medicare coverage for certain uses. That development shifts cannabis closer to pharmaceuticals than counterculture. The industry remains regulated and fragmented, but it now operates with fewer contradictions. Sometimes the biggest changes arrive through paperwork rather than protests. 

Howard Hughes decided that owning buildings alone felt slightly under diversified. The company announced a $2.1B acquisition of Vantage Insurance, signaling a deliberate step away from relying purely on property cycles. Instead of betting exclusively on cranes and zoning approvals, management chose underwriting models and recurring premiums, which tend to age more gracefully during economic uncertainty.

The structure of the deal reflects patience rather than urgency. Funding includes cash and a loan facility arranged by Pershing Square, paired with a buyback mechanism tied to Vantage’s book value over time. This approach limits upfront strain while granting full economic exposure. It reads less like a splashy expansion and more like a spreadsheet driven courtship.

Vantage adds something Howard Hughes historically lacked. Insurance underwriting delivers repeatable cash flows that do not depend on buyers showing up for open houses. Its data driven approach introduces analytics instead of optimism into the portfolio. That distinction matters when real estate demand slows or financing costs rise.

This move nudges Howard Hughes toward a holding company identity. Investors may eventually view it less as a property developer and more as a capital allocator with diversified earnings streams. If execution remains disciplined, the acquisition could smooth earnings volatility and recalibrate expectations. Sometimes diversification arrives quietly, wearing actuarial tables instead of hard hats.